These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36462492)
1. Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer. Shen J; Xie M; Xu Y; Qian Q; Qiu T; Shi W; Ren D; Ji J; Huang J Biochem Biophys Res Commun; 2023 Jan; 638():184-191. PubMed ID: 36462492 [TBL] [Abstract][Full Text] [Related]
2. USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1. Chen L; Xu Z; Li Q; Feng Q; Zheng C; Du Y; Yuan R; Peng X Cell Death Dis; 2021 Sep; 12(10):887. PubMed ID: 34584067 [TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 28 deubiquitinates TCF7L2 to govern the action of the Wnt signaling pathway in hepatic carcinoma. Sun X; Cai M; Wu L; Zhen X; Chen Y; Peng J; Han S; Zhang P Cancer Sci; 2022 Oct; 113(10):3463-3475. PubMed ID: 35880246 [TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase USP28 stabilizes the expression of RecQ family helicases and maintains the viability of triple negative breast cancer cells. Wang J; Dong Y; Ma H; Wu L; Zhen X; Tang L; Jin J; Han S; Zhang P; Peng J J Biol Chem; 2022 Jan; 298(1):101443. PubMed ID: 34822842 [TBL] [Abstract][Full Text] [Related]
5. The deubiquitinase USP28 controls intestinal homeostasis and promotes colorectal cancer. Diefenbacher ME; Popov N; Blake SM; Schülein-Völk C; Nye E; Spencer-Dene B; Jaenicke LA; Eilers M; Behrens A J Clin Invest; 2014 Aug; 124(8):3407-18. PubMed ID: 24960159 [TBL] [Abstract][Full Text] [Related]
6. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage. Jin C; Einig E; Xu W; Kollampally RB; Schlosser A; Flentje M; Popov N Nucleic Acids Res; 2024 Apr; 52(6):3011-3030. PubMed ID: 38227944 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth. Zhang L; Xu B; Qiang Y; Huang H; Wang C; Li D; Qian J J Cell Mol Med; 2015 Apr; 19(4):799-805. PubMed ID: 25656529 [TBL] [Abstract][Full Text] [Related]
8. The USP18-FBXO6 axis maintains the malignancy of ovarian cancer. Li G; Shi W; Xu Y; Li K; Chen Z; Lv M; Lv J; Qiu T; Qian Q; Ji J; Liu W; Liu B; Zhao Y Biochem Biophys Res Commun; 2022 Feb; 593():101-107. PubMed ID: 35063764 [TBL] [Abstract][Full Text] [Related]
9. USP28 promotes aerobic glycolysis of colorectal cancer by increasing stability of FOXC1. Liu Z; Chen M; Xu X; Zhang L; Pan Y; Chen D Acta Biochim Pol; 2021 Jun; 68(4):633-639. PubMed ID: 34106567 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of deubiquitinase USP28 attenuates cyst growth in autosomal dominant polycystic kidney disease. Ren Y; Zhu X; Fu K; Zhang H; Zhao W; Lin Y; Fang Q; Wang J; Chen Y; Guo D Biochem Pharmacol; 2023 Jan; 207():115355. PubMed ID: 36442624 [TBL] [Abstract][Full Text] [Related]
11. USP28 regulates deubiquitination of histone H2A and cell proliferation. Li F; Han H; Sun Q; Liu K; Lin N; Xu C; Zhao Z; Zhao W Exp Cell Res; 2019 Jun; 379(1):11-18. PubMed ID: 30910399 [TBL] [Abstract][Full Text] [Related]
12. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia. Xu J; Peng J; Sun S; Wang D; Yuan W; Yang X; Shi T; Wang R; Liu H; Zhang P; Zhu HH Br J Haematol; 2024 Jun; 204(6):2301-2318. PubMed ID: 38685813 [TBL] [Abstract][Full Text] [Related]
13. Stabilization of PIM Kinases in Hypoxia Is Mediated by the Deubiquitinase USP28. Toth RK; Solomon R; Warfel NA Cells; 2022 Mar; 11(6):. PubMed ID: 35326457 [TBL] [Abstract][Full Text] [Related]
14. USP28: Oncogene or Tumor Suppressor? A Unifying Paradigm for Squamous Cell Carcinoma. Prieto-Garcia C; Tomašković I; Shah VJ; Dikic I; Diefenbacher M Cells; 2021 Oct; 10(10):. PubMed ID: 34685632 [TBL] [Abstract][Full Text] [Related]
15. FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development. Ji J; Qian Q; Cheng W; Ye X; Jing A; Ma S; Ding Y; Ma X; Wang Y; Sun Q; Wang X; Chen Y; Zhu L; Yuan Q; Xu M; Qin J; Ma L; Yang J; Zhang M; Geng T; Wang S; Wang D; Song Y; Zhang B; Xu Y; Xu L; Liu S; Liu W; Liu B Cell Death Dis; 2024 May; 15(5):332. PubMed ID: 38740744 [TBL] [Abstract][Full Text] [Related]
16. UBE2S promotes the development of ovarian cancer by promoting PI3K/AKT/mTOR signaling pathway to regulate cell cycle and apoptosis. Zhang M; Liu Y; Yin Y; Sun Z; Wang Y; Zhang Z; Li F; Chen X Mol Med; 2022 Jun; 28(1):62. PubMed ID: 35658829 [TBL] [Abstract][Full Text] [Related]
17. Differential Oligomerization of the Deubiquitinases USP25 and USP28 Regulates Their Activities. Sauer F; Klemm T; Kollampally RB; Tessmer I; Nair RK; Popov N; Kisker C Mol Cell; 2019 May; 74(3):421-435.e10. PubMed ID: 30926243 [TBL] [Abstract][Full Text] [Related]
18. Distinct USP25 and USP28 Oligomerization States Regulate Deubiquitinating Activity. Gersch M; Wagstaff JL; Toms AV; Graves B; Freund SMV; Komander D Mol Cell; 2019 May; 74(3):436-451.e7. PubMed ID: 30926242 [TBL] [Abstract][Full Text] [Related]
19. Targeting deubiquitinase USP28 for cancer therapy. Wang X; Liu Z; Zhang L; Yang Z; Chen X; Luo J; Zhou Z; Mei X; Yu X; Shao Z; Feng Y; Fu S; Zhang Z; Wei D; Jia L; Ma J; Guo X Cell Death Dis; 2018 Feb; 9(2):186. PubMed ID: 29415985 [TBL] [Abstract][Full Text] [Related]
20. The deubiquitinase USP28 stabilizes LSD1 and confers stem-cell-like traits to breast cancer cells. Wu Y; Wang Y; Yang XH; Kang T; Zhao Y; Wang C; Evers BM; Zhou BP Cell Rep; 2013 Oct; 5(1):224-36. PubMed ID: 24075993 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]